Clinical Trials in New York

Showing 3621-3640 of 22,668 trials

Diagnosing Clinically Significant Prostate Cancer In African American and White Men With Elevated PSA

NCT03234556

This randomized phase II trial studies how well systematic random biopsy or magnetic resonance imaging (MRI)-ultrasound image (US) fusion biopsy work in diagnosing prostate cancer in patients with elevated prostate specific antigen. Systematic random biopsy and MRI-US fusion biopsy may work better in improving the accuracy of prostate cancer detection.

Health Status UnknownElevated PSA

University of Southern California288 participantsStarted Sep 2017

Los Angeles, California, United States • Baltimore, Maryland, United States • Detroit, Michigan, United States +1 more locations

COMPLETEDPhase 2< 1 mile

An Efficacy and Safety Study of Niraparib in Men With Metastatic Castration-Resistant Prostate Cancer and DNA-Repair Anomalies

NCT02854436

The purpose of this study is to assess the efficacy, safety, and pharmacokinetics of niraparib in men with metastatic castration-resistant prostate cancer (mCRPC) and deoxyribonucleic acid (DNA) repair anomalies.

Prostatic Neoplasms

Janssen Research & Development, LLC289 participantsStarted Aug 2016

Tucson, Arizona, United States • Los Angeles, California, United States • Riverside, California, United States +107 more locations

Diagnosing Clinically Significant Prostate Cancer In African American and White Men With Elevated PSA

An Efficacy and Safety Study of Niraparib in Men With Metastatic Castration-Resistant Prostate Cancer and DNA-Repair Anomalies

Find Trials by Condition in New York

NBI-1065845-MDD3026: Study to Assess the Efficacy and Safety of NBI-1065845 as an Adjunctive Treatment in Participants With Major Depressive Disorder (MDD)

A Phase 3 Study to Assess Efficacy and Safety of Tafasitamab Plus Lenalidomide and Rituximab Compared to Placebo Plus Lenalidomide and Rituximab in Patients With Relapsed/Refractory (R/R) Follicular Lymphoma or Marginal Zone Lymphoma.

Cleaner Air for Lower Cardiometabolic Risk

The HistoSonics Edison™ System for Treatment of Primary Solid Renal Tumors Using Histotripsy (#HOPE4KIDNEY)

Capivasertib+Paclitaxel as First Line Treatment for Patients With Locally Advanced or Metastatic TNBC

Phagenyx® Registry Study

Atezolizumab and Pre-Surgical Brain Radiation Therapy for Glioblastoma Multiforme

Spreading Depolarizations in Traumatic Brain Injury

Multi-Arm Multi-Stage Adaptive Platform Trial (APT) for the Acute Treatment of Traumatic Brain Injury

Study of Atezolizumab in Combination With Cabozantinib Versus Docetaxel in Patients With Metastatic Non-Small Cell Lung Cancer Previously Treated With an Anti-PD-L1/PD-1 Antibody and Platinum-Containing Chemotherapy

A Study to Compare How Well Gadoquatrane Works and Its Safety With an Already Available Contrast Agent for MRI in People With Any Known or Suspected Problems of the Body (Except Brain or Spinal Cord-related Problems)

First-in-human Trial of STC-1010, an Immunotherapy, in Patients With Unresectable Locally Advanced or Metastatic Colorectal Cancer

Phase 2b/3 Study to Assess ABP-671 a Novel URAT1 Inhibitor in Participants With Gout

Strategic Help With Immunoglobulin to Enhance Protect Against Late Disease (CMV)

Advanced XLIF Monitoring Multicenter Study

A Study of RM-718 in Healthy Subjects and Patients With MC4R Pathway Impairment

A Study to Investigate Multiple Sclerosis Relapse Prevention With mRNA-1195 Compared With Placebo in Participants Aged 18 to ≤55 Years

Dupilumab in Allergic Fungal Rhinosinusitis (AFRS) (LIBERTY-AFRS-AI)